Syndax Pharmaceuticals' stock fell more than 11% after its drug axatilimab failed to meet the primary endpoint in a Phase 2 trial for idiopathic pulmonary fibrosis (IPF). The trial showed no benefit in lung function decline, leading Syndax to halt further IPF development. Investors who suffered losses in the selloff may be eligible for compensation, as a securities law investigation is underway.
Syndax Pharmaceuticals' recent stock decline is noted alongside Pluang's health sector data for context. For readers following health stocks, here is Pluang's market snapshot as of Oct 14, 2026 06:21 WIB: out of 128 priced health-sector US stocks, 29 rose and 99 fell. Notable movers include JNJ at USD 249.35 with a 1-day change of -5.45% and a typical hold time of 129 days, HRTX at USD 0.39 down 5.32% with a 36-day hold, and TXG at USD 71.80 down 4.51% with a 92-day hold time and 100% buy order activity.
Particula has assigned a AAA-rating to WisdomTree Treasury Money Market Digital Fund (WTGXX), a $1.2 billion tokenized money market fund. The fund invests in short-term U.S. Treasury securities and government money market funds, aiming to preserve ca...
AlphaPepe's cryptocurrency presale has surpassed 12,500 holders and raised nearly $3 million before its first public exchange listing, signaling strong community growth. More than 100 new holders join daily, with a fifth centralized exchange (CEX) pa...
ZenaTech announced a 27.1% organic revenue growth in its Drone as a Service (DaaS) operations in 2026, driven by integrating AI and drones into surveying and inspection workflows. The company expects Q3 2026 revenues between C$13.4 million and C$14.8...
U.S. President Donald Trump announced that Taiwan has agreed to purchase 30% of the gas from the proposed $50 billion Alaska LNG pipeline project for the next 20 years. This deal follows Taiwan's state-owned CPC Corp's prior agreement to buy LNG and ...
Nvidia CEO Jensen Huang has reaffirmed his long-standing forecast that global spending on AI infrastructure will surge to between $3 trillion and $4 trillion by 2030. This projection highlights the massive growth potential in the AI sector, driven by...
